Loading...
Metabolics Shift And New Capacity Will Support Long Term Peptide CDMO Opportunity
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
1Y
10.6%7D
-4.3%1Y
10.6%7D
-4.3%You can edit this narrative until Jan 25 8:05 AM. Then, changes will post as Updates.